The available semaglutide headache relief guidance supports reviewing hydration, meals, glucose, and dose timing
Current Canadian Pricing Landscape According to recent market data, Canadians currently pay between $300 and $400 monthly for brand-name GLP-1 medications like Ozempic and Wegovy, with costs varying by dose and pharmacy
doi: 10.2337/db13-0140 [DOI] [PMC free article] [PubMed] [Google Scholar] 21
To evaluate for comprehensiveness, the content of PROMs was mapped against established health-related quality-of-life frameworks
The two main GLP-1 medications approved for weight management in Australia are: Liraglutide (Saxenda) : Administered as a daily injection Semaglutide (Wegovy) : Administered weekly (though many Australians access the diabetes version, Ozempic, for weight loss) While these medications were originally developed for type 2 diabetes management, their significant weight loss effects quickly became apparent, leading to their approval for obesity treatment